Skip to main content
Top
Published in: Malaria Journal 1/2011

Open Access 01-12-2011 | Research

Baseline results of the first malaria indicator survey in Iran at the health facility level

Authors: Ahmad Raiesi, Fatemeh Nikpour, Alireza Ansari-Moghaddam, Mansoor Ranjbar, Fatemeh Rakhshani, Mahdi Mohammadi, Aliakbar Haghdost, Rahim Taghizadeh-Asl, Mohammad Sakeni, Reza Safari, Mehdi Saffari

Published in: Malaria Journal | Issue 1/2011

Login to get access

Abstract

Background

Malaria continues to be a global public health challenge, particularly in developing countries. Delivery of prompt and effective diagnosis and treatment of malaria cases, detection of malaria epidemics within one week of onset and control them in less than a month, regular disease monitoring and operational classification of malaria are among the major responsibilities of the national malaria programme. The study was conducted to determine these indicators at the different level of primary health care facilities in malaria-affected provinces of Iran

Methods

In this survey, data was collected from 223 health facilities including health centres, malaria posts, health houses and hospitals as well as the profile of all 5, 836 recorded malaria cases in these facilities during the year preceding the survey. Descriptive statistics (i.e. frequencies, percentages) were used to summarize the results and Chi square test was used to analyse data.

Results

All but one percent of uncomplicated cases took appropriate and correctly-dosed of anti-malarial drugs in accordance to the national treatment guideline. A larger proportion of patients [85.8%; 95% CI: 84.8 - 86.8] were also given complete treatment including anti-relapse course, in line with national guidelines. About one third [35.0%; 95% CI: 33.6 - 36.4] of uncomplicated malaria cases were treated more than 48 hours after first symptoms onset. Correspondingly, half of severe malaria cases took recommended anti-malarial drugs for severe or complicated disease more than 48 hours of onset of first symptoms. The latter cases had given regular anti-malarial drugs promptly.
The majority of malaria epidemics [97%; 95% CI: 90.6 - 100] in study areas were detected within one week of onset, but only half of epidemics were controlled within four weeks of detection. Just half of target districts had at least one health facility/emergency site with adequate supply and equipment stocks. Nevertheless, only one-third of them [33% (95% CI: 0.00 - 67.8)] had updated inventory of malaria foci on quarterly basis.

Conclusion

To sum up, malaria case management still constitutes a public health problem in Iran. Additionally, data suggest scarcity in management and evaluation of malaria foci, detection and control of malaria epidemics as well as assignment of emergency sites across different regions of the country. Consequently, massive and substantial investments need to be made at the Ministry of Health to coordinate national malaria control programmes towards achieving determined goals and targets.
Appendix
Available only for authorised users
Literature
2.
go back to reference World Health Organization: World malaria report. 2009, Geneva, Switzerland World Health Organization: World malaria report. 2009, Geneva, Switzerland
3.
go back to reference Sadrizadeh B: Malaria in the World, in the Eastern Mediterranean region and in Iran. Review article. 2001, 1-13. . WHO/EMRO Report Sadrizadeh B: Malaria in the World, in the Eastern Mediterranean region and in Iran. Review article. 2001, 1-13. . WHO/EMRO Report
4.
go back to reference Haghdoost AA, Alexander N, Cox J: Modelling of malaria temporal variations in Iran. Trop Med Int Health. 2008, 13: 1501-1508. 10.1111/j.1365-3156.2008.02166.x.CrossRefPubMed Haghdoost AA, Alexander N, Cox J: Modelling of malaria temporal variations in Iran. Trop Med Int Health. 2008, 13: 1501-1508. 10.1111/j.1365-3156.2008.02166.x.CrossRefPubMed
5.
go back to reference Edrissian GH: Malaria in Iran: Past and present situation. Iranian J Parasitol. 2006, 1: 1-14. Edrissian GH: Malaria in Iran: Past and present situation. Iranian J Parasitol. 2006, 1: 1-14.
6.
go back to reference Khalili MB, Anvari-Tafti MH, Sadeh M: Epidemiological pattern of malarial disease in the province of Yazd, Iran (Since 1986-2006). World Journal of Medical Sciences. 2009, 4: 41-45. Khalili MB, Anvari-Tafti MH, Sadeh M: Epidemiological pattern of malarial disease in the province of Yazd, Iran (Since 1986-2006). World Journal of Medical Sciences. 2009, 4: 41-45.
8.
go back to reference World Health Organization: Malaria elimination: a field manual for low and moderate endemic countries. Geneva, Switzerland World Health Organization: Malaria elimination: a field manual for low and moderate endemic countries. Geneva, Switzerland
9.
go back to reference Roll Back Malaria Partnership: The Global Malaria Action Plan: for a malaria-free world. 2008, Geneva, Switzerland Roll Back Malaria Partnership: The Global Malaria Action Plan: for a malaria-free world. 2008, Geneva, Switzerland
10.
go back to reference Mohammadi M, Ansari-Moghaddam A, Raiesi A, Rakhshani F, Nikpour F, Haghdost A, Ranjbar M, Taghizadeh-Asl R, Sakeni M, Safari R, Saffari M: Baseline results of the first malaria indicator survey in Iran at household level. Malar J. 2011, 10: 277-10.1186/1475-2875-10-277.PubMedCentralCrossRefPubMed Mohammadi M, Ansari-Moghaddam A, Raiesi A, Rakhshani F, Nikpour F, Haghdost A, Ranjbar M, Taghizadeh-Asl R, Sakeni M, Safari R, Saffari M: Baseline results of the first malaria indicator survey in Iran at household level. Malar J. 2011, 10: 277-10.1186/1475-2875-10-277.PubMedCentralCrossRefPubMed
11.
go back to reference Noor AM: Djibouti National Malaria Indicator Survey 2008-2009. 2009, Submitted to the World Health Organization, Eastern Mediterranean Regional Office, Cairo, Egypt Noor AM: Djibouti National Malaria Indicator Survey 2008-2009. 2009, Submitted to the World Health Organization, Eastern Mediterranean Regional Office, Cairo, Egypt
12.
go back to reference Ministry of Health (MOH) [Rwanda], National Institute of Statistics of Rwanda (NISR), and ICF Macro: Rwanda Interim Demographic and Health Survey 2007-08. 2009, Calverton, Maryland, USA: MOH, NISR, and ICF Macro Ministry of Health (MOH) [Rwanda], National Institute of Statistics of Rwanda (NISR), and ICF Macro: Rwanda Interim Demographic and Health Survey 2007-08. 2009, Calverton, Maryland, USA: MOH, NISR, and ICF Macro
13.
go back to reference Consultoria de Serviços e Pesquisas-COSEP Lda., Consultoria de Gestão e Administração em Saúde-Consaúde Lda. [Angola], and Macro International Inc: Angola Malaria Indicator Survey 2006-07. 2007, Calverton, Maryland: COSEP Lda., Consaúde Lda., and Macro International Inc Consultoria de Serviços e Pesquisas-COSEP Lda., Consultoria de Gestão e Administração em Saúde-Consaúde Lda. [Angola], and Macro International Inc: Angola Malaria Indicator Survey 2006-07. 2007, Calverton, Maryland: COSEP Lda., Consaúde Lda., and Macro International Inc
14.
go back to reference National Malaria Control Program (NMCP) [Liberia], Ministry of Health and Social Welfare, Liberia Institute of Statistics and Geo-Information Services (LISGIS), and ICF Macro: Liberia Malaria Indicator Survey 2009. 2009, Monrovia, Liberia: NMCP, LISGIS, and ICF Macro National Malaria Control Program (NMCP) [Liberia], Ministry of Health and Social Welfare, Liberia Institute of Statistics and Geo-Information Services (LISGIS), and ICF Macro: Liberia Malaria Indicator Survey 2009. 2009, Monrovia, Liberia: NMCP, LISGIS, and ICF Macro
15.
go back to reference National Malaria Control Center [Zambia], Ministry of Health; Central Statistical Office; Malaria Control and Evaluation Partnership in Africa (MACEPA), a program at PATH; the United States President's Malaria Initiative; the World Bank; UNICEF; the World Health Organization; and the University of Zambia: Zambia National Malaria Indicator Survey. 2008, Lusaka, Zambia National Malaria Control Center [Zambia], Ministry of Health; Central Statistical Office; Malaria Control and Evaluation Partnership in Africa (MACEPA), a program at PATH; the United States President's Malaria Initiative; the World Bank; UNICEF; the World Health Organization; and the University of Zambia: Zambia National Malaria Indicator Survey. 2008, Lusaka, Zambia
16.
go back to reference Roll Back Malaria Monitoring and Evaluation Reference Group, World Health Organization, United Nations Children's Fund, MEASURE DHS, MEASURE Evaluation, and U.S. Centers for Disease Control and Prevention: Malaria Indicator Survey: Basic documentation for survey design and implementation. 2005, Calverton, Maryland: MEASURE Evaluation Roll Back Malaria Monitoring and Evaluation Reference Group, World Health Organization, United Nations Children's Fund, MEASURE DHS, MEASURE Evaluation, and U.S. Centers for Disease Control and Prevention: Malaria Indicator Survey: Basic documentation for survey design and implementation. 2005, Calverton, Maryland: MEASURE Evaluation
17.
go back to reference Monitoring and Evaluation Toolkit: HIV/AIDS, Tuberculosis, and Malaria. The Global Fund to Fight AIDS, Tuberculosis & Malaria. Geneva, Switzerland, ISBN 92-9224-029-3.2006, Accessed:9/3/2010, [http://www.theglobalfund.org] Monitoring and Evaluation Toolkit: HIV/AIDS, Tuberculosis, and Malaria. The Global Fund to Fight AIDS, Tuberculosis & Malaria. Geneva, Switzerland, ISBN 92-9224-029-3.2006, Accessed:9/3/2010, [http://​www.​theglobalfund.​org]
18.
go back to reference Roll Back Malaria, MEASURE Evaluation, World Health Organization, UNICEF: Guidelines for Core Population Coverage Indicators for Roll Back Malaria: To Be Obtained from Household Surveys. 2006, MEASURE Evaluation: Calverton, Maryland Roll Back Malaria, MEASURE Evaluation, World Health Organization, UNICEF: Guidelines for Core Population Coverage Indicators for Roll Back Malaria: To Be Obtained from Household Surveys. 2006, MEASURE Evaluation: Calverton, Maryland
19.
go back to reference Chuma J, Abuya T, Memusi D, Juma E, Akhwale W, Ntwiga J, Nyandigisi A, Tetteh G, Shretta R, Amin A: Reviewing the literature on access to prompt and effective malaria treatment in Kenya: implications for meeting the Abuja targets. Malar J. 2009, 8: 243-10.1186/1475-2875-8-243.PubMedCentralCrossRefPubMed Chuma J, Abuya T, Memusi D, Juma E, Akhwale W, Ntwiga J, Nyandigisi A, Tetteh G, Shretta R, Amin A: Reviewing the literature on access to prompt and effective malaria treatment in Kenya: implications for meeting the Abuja targets. Malar J. 2009, 8: 243-10.1186/1475-2875-8-243.PubMedCentralCrossRefPubMed
20.
go back to reference Hetzel MW, Obrist B, Lengeler C, Msechu JJ, Nathan R, Dillip A, Makemba AM, Mshana C, Schulze A, Mshinda H: Obstacles to prompt and effective malaria treatment lead to low community-coverage in two rural districts of Tanzania. BMC Public Health. 2008, 8: 317-10.1186/1471-2458-8-317.PubMedCentralCrossRefPubMed Hetzel MW, Obrist B, Lengeler C, Msechu JJ, Nathan R, Dillip A, Makemba AM, Mshana C, Schulze A, Mshinda H: Obstacles to prompt and effective malaria treatment lead to low community-coverage in two rural districts of Tanzania. BMC Public Health. 2008, 8: 317-10.1186/1471-2458-8-317.PubMedCentralCrossRefPubMed
21.
go back to reference Jima D, Getachew A, Bilak H, Steketee RW, Emerson PM, Graves PM, Gebre T, Reithinger R, Hwang J, Ethiopia Malaria Indicator Survey Working Group: Malaria indicator survey 2007, Ethiopia: coverage and use of major malaria prevention and control interventions. Malar J. 2010, 9: 58-10.1186/1475-2875-9-S2-P58.PubMedCentralCrossRefPubMed Jima D, Getachew A, Bilak H, Steketee RW, Emerson PM, Graves PM, Gebre T, Reithinger R, Hwang J, Ethiopia Malaria Indicator Survey Working Group: Malaria indicator survey 2007, Ethiopia: coverage and use of major malaria prevention and control interventions. Malar J. 2010, 9: 58-10.1186/1475-2875-9-S2-P58.PubMedCentralCrossRefPubMed
22.
go back to reference Alba S, Dillip A, Hetzel MW, Mayumana L, Mshana C, Makemba A, Alexander M, Obrist B, Schulze A, Kessy F, Mshinda H, Lengeler C: Improvements in access to malaria treatment in Tanzania following community, retail sector and health facility interventions -- a user perspective. Malar J. 2010, 9: 163-10.1186/1475-2875-9-163.PubMedCentralCrossRefPubMed Alba S, Dillip A, Hetzel MW, Mayumana L, Mshana C, Makemba A, Alexander M, Obrist B, Schulze A, Kessy F, Mshinda H, Lengeler C: Improvements in access to malaria treatment in Tanzania following community, retail sector and health facility interventions -- a user perspective. Malar J. 2010, 9: 163-10.1186/1475-2875-9-163.PubMedCentralCrossRefPubMed
23.
go back to reference Checchi F, Cox J, Balkan S, Tamrat A, Priotto G, Alberti KP, Zurovac D, Guthmann JP: Malaria epidemics and interventions, Kenya, Burundi, Southern Sudan, and Ethiopia, 1999-2004. Emerg Infect Dis. 2006, 12: 1477-1485.PubMedCentralCrossRefPubMed Checchi F, Cox J, Balkan S, Tamrat A, Priotto G, Alberti KP, Zurovac D, Guthmann JP: Malaria epidemics and interventions, Kenya, Burundi, Southern Sudan, and Ethiopia, 1999-2004. Emerg Infect Dis. 2006, 12: 1477-1485.PubMedCentralCrossRefPubMed
24.
go back to reference Coleman M, Coleman M, Abuza AM, Gerdalize K, Coetzee M, Durrheim DN: Evaluation of an operational malaria outbreak identification and response system in Mpumalanga Province, South Africa. Malar J. 2008, 7: 69-10.1186/1475-2875-7-69.PubMedCentralCrossRefPubMed Coleman M, Coleman M, Abuza AM, Gerdalize K, Coetzee M, Durrheim DN: Evaluation of an operational malaria outbreak identification and response system in Mpumalanga Province, South Africa. Malar J. 2008, 7: 69-10.1186/1475-2875-7-69.PubMedCentralCrossRefPubMed
Metadata
Title
Baseline results of the first malaria indicator survey in Iran at the health facility level
Authors
Ahmad Raiesi
Fatemeh Nikpour
Alireza Ansari-Moghaddam
Mansoor Ranjbar
Fatemeh Rakhshani
Mahdi Mohammadi
Aliakbar Haghdost
Rahim Taghizadeh-Asl
Mohammad Sakeni
Reza Safari
Mehdi Saffari
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2011
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-10-319

Other articles of this Issue 1/2011

Malaria Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.